Press Release
Category Added in a WPeMatico Campaign
-
Six Taipei Biotechs Head to BIO 2026 in San Diego, With Precision Medicine, Drug Delivery, and Bioprocess Innovation in Focus
SAN DIEGO, June 18, 2026 /PRNewswire/ — The BIO International Convention, held each June in San Diego, is where dealmaking…
Read More » -
VinFast VF 8: The Electric SUV That Puts Family First
IRVINE, Calif., June 18, 2026 /PRNewswire/ — There’s a particular kind of exhaustion that comes with long family road trips.…
Read More » -
Envoy Global Releases 11th Annual Immigration Trends Report as Employers Adapt to Rapid Changes in U.S. Immigration Policy
CHICAGO, June 18, 2026 /PRNewswire/ — Envoy Global, Inc., the leading corporate immigration services provider, today released its U.S. Corporate…
Read More » -
Newo.ai to showcase AI receptionists at InstallerSHOW
Live demonstrations and a prize drawing highlight platform’s presence at the UK’s largest event for HVAC, plumbing and building services…
Read More » -
THRYVE Automation announces advanced end-to-end automation solutions to help manufacturers meet modern AI and workforce challenges
The new unified brand built on the engineering heritage of Jewett Automation, Filtration Technology Systems (FTS), and S&J Precision officially…
Read More » -
Airport Navigational Aids Market worth $4.41 billion by 2031 – Exclusive Report by MarketsandMarkets™
DELRAY BEACH, Fla., June 18, 2026 /PRNewswire/ — According to MarketsandMarkets™, the airport navigational aids market is estimated at USD 3.53…
Read More » -
IASO Bio Announces NDA Approval of Equecabtagene Autoleucel by the Singapore Health Sciences Authority (HSA) for the Treatment of Relapsed or Refractory Multiple Myeloma, Marking a Key Milestone in International Commercialization
SHANGHAI, NANJING, and PLEASANTON, Calif., June 18, 2026 /PRNewswire/ — IASO Biotechnology (“IASO Bio”), a commercial-stage biopharmaceutical company focused on…
Read More » -
Zoomlion Highlights AI, Green Technology and Global R&D Priorities at Seventh Technology Innovation Conference
CHANGSHA, China, June 18, 2026 /PRNewswire/ — Zoomlion Heavy Industry Science & Technology Co., Ltd. (“Zoomlion”) hosted its seventh Science…
Read More » -
Uxin Announces Management Share Purchase Plan
BEIJING, June 18, 2026 /PRNewswire/ — Uxin Limited (“Uxin” or the “Company”) (Nasdaq: UXIN), a leading used car retailer in…
Read More » -
TORL BioTherapeutics Presents Preliminary Safety and Efficacy Data of Ixotatug Vedotin (TORL-1-23) in Combination with Bevacizumab in Recurrent Ovarian Cancer at ESMO Gynaecological Cancers Congress 2026
Objective response rate across all 29 participants was 32.1%; Favorable disease control rate (92.9%) across all participants was observed Data…
Read More »